[
  {
    "id": "doi:10.1016/j.jinf.2024.106130",
    "title": "Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes",
    "authors": [
      "Gail Hayward",
      "et al."
    ],
    "year": 2024,
    "claims": [
      "C1"
    ]
  },
  {
    "id": "doi:10.1001/jama.2022.18590",
    "title": "Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial",
    "authors": [
      "Susanna Naggie",
      "et al."
    ],
    "year": 2022,
    "claims": [
      "C1"
    ]
  },
  {
    "id": "doi:10.1001/jama.2023.1650",
    "title": "Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial",
    "authors": [
      "Susanna Naggie",
      "et al."
    ],
    "year": 2023,
    "claims": [
      "C1"
    ]
  },
  {
    "id": "doi:10.1056/NEJMoa2201662",
    "title": "Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19",
    "authors": [
      "Carolyn T. Bramante",
      "et al."
    ],
    "year": 2022,
    "claims": [
      "C1"
    ]
  },
  {
    "id": "doi:10.1056/NEJMoa2115869",
    "title": "Effect of Early Treatment with Ivermectin among Patients with Covid-19",
    "authors": [
      "Gilmar Reis",
      "et al."
    ],
    "year": 2022,
    "claims": [
      "C1"
    ]
  },
  {
    "id": "doi:10.1001/jama.2024.8712",
    "title": "Errors in Results From Erroneous Exclusion of Participants in Analysis",
    "authors": [
      "JAMA"
    ],
    "year": 2024,
    "claims": [
      "C1"
    ]
  },
  {
    "id": "doi:10.1186/s12874-015-0091-1",
    "title": "Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies",
    "authors": [
      "Christian R\u00f6ver",
      "Guido Knapp",
      "Tim Friede"
    ],
    "year": 2015,
    "claims": [
      "C1"
    ]
  }
]